Share buybacks in Ericsson during the period October 5 - October 9, 2026
STOCKHOLM, Oct. 12, 2026, 02:57 GMT-04
Ericsson
Read full article →EMSF Lisboa receives international English-language press releases through its partnership with PR Newswire and makes them available in Portugal. EMSF organises, indexes and classifies the material by sector to support consultation.
STOCKHOLM, Oct. 12, 2026, 02:57 GMT-04
Ericsson
Read full article →
ESPOO, Finland, Oct. 12, 2026, 02:54 GMT-04
Valmet-Oyj
Read full article →
LINKÖPING, Sweden, Oct. 12, 2026, 02:47 GMT-04
Sectra
Read full article →
STUTTGART, Germany, Oct. 12, 2026, 02:29 GMT-04
Raytron-OEM
Read full article →
BREDA, Netherlands, Oct. 12, 2026, 02:20 GMT-04
BUas-supermarket-poll
Read full article →Press releases · last 48 hours
Compared with the previous 48 hours:
↑ Increased ·
→ Unchanged ·
↓ Decreased
Equal frequency shares the same position.
TAIPEI, Oct. 12, 2026, 02:00 GMT-04
Hon-Hai-Technology-Gr
Read full article →
FORT LEE, N.J. and SEOUL, South Korea, Oct. 12, 2026, 02:00 GMT-04
NEWEN-AI
Read full article →
BLOMBERG, Germany, Oct. 12, 2026, 02:00 GMT-04
Phoenix-Contact
Read full article →
TORONTO, Oct. 12, 2026, 00:15 GMT-04
3iQ
Read full article →
SINGAPORE and AMSTERDAM, Oct. 12, 2026, 00:00 GMT-04
SWI-Group
Read full article →
SINGAPORE, Oct. 12, 2026, 23:45 GMT-04
Singapore-Internation
Read full article →
LONDON, Oct. 12, 2026, 21:00 GMT-04
Black-British-Busines
Read full article →
SEOUL, South Korea, Oct. 12, 2026, 21:00 GMT-04
Arirang-TV
Read full article →
NEW YORK, Oct. 11, 2026, 10:15 GMT-04
The-Lego-Group
Read full article →
CANARY ISLANDS, Spain, Oct. 10, 2026, 16:21 GMT-04
Starmus-Foundation
Read full article →
RIYADH, Saudi Arabia, Oct. 10, 2026, 15:15 GMT-04
KAPSARC
Read full article →
CHENGDU, China, Oct. 10, 2026, 12:31 GMT-04
KAILAS
Read full article →
CHANGSHA, China, Oct. 10, 2026, 11:20 GMT-04
Zoomlion
Read full article →
Shenzhen, China, Oct. 10, 2026, 10:59 GMT-04
Ninenovo
Read full article →
MILAN, Oct. 10, 2026, 10:31 GMT-04
Kexing-Biopharm
Read full article →